Privacy Act (1974)

The Privacy Act is a United States federal law that was enacted in 1974 to establish a set of privacy standards for the collection, maintenance, and dissemination of personal information by federal agencies. The act provides individuals with certain rights to access and amend their own personal information and also places restrictions on the disclosure of that information to third parties.

Key features of the Privacy Act include:

  • Definition of personal information: The act defines personal information as any information that pertains to an individual, including their name, social security number, address, and other identifying details.

  • Access to personal information: Individuals have the right to access and review their own personal information maintained by federal agencies, and can request that any inaccuracies be corrected.

  • Disclosure restrictions: Federal agencies are prohibited from disclosing an individual's personal information to third parties without their consent, except in certain limited circumstances.

  • Penalties for violations: The act includes provisions for civil and criminal penalties for individuals or agencies that violate its provisions, including fines and imprisonment.

Regarding employee benefits, the Privacy Act may impact the collection, maintenance, and dissemination of personal information related to employees by federal agencies. It may also require employers to obtain consent from employees before sharing their personal information with third parties. Additionally, the act may impact the handling of employee medical information, such as through the Health Insurance Portability and Accountability Act (HIPAA) privacy rules, which build on the Privacy Act's framework.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.